Recent studies suggested that even non-obstructive coronary artery disease (CAD) increases major cardiovascular adverse events (MACE) rate. Aim of this study was to evaluate whether coronary computed tomography angiography (CCTA) may detect specific plaque characteristics that may affect prognosis in patients with non-obstructive CAD.
Background
Coronary artery disease (CAD) is one of the main causes of morbidity and mortality in industrialized countries. 1 Of note, sudden cardiac death has been reported to occur in 50% of men and 64% of women without previous cardiovascular symptoms. 1 Acute coronary thrombosis has been identified as the main cause of myocardial infarction and increased lipid content, macrophage infiltration, intra-plaque haemorrhages, thin-cap fibroatheroma (TCFA), and positive remodelling are typical pathology features of vulnerable atherosclerotic plaques. In several instances, atheromatous plaques with these characteristics are not flow limiting, but they are prone to rupture and to produce ACS nevertheless. 2, 3 Clinical prospective studies confirmed that angiographically mild lesions may be responsible for adverse cardiovascular events at long-term follow-up, especially if a TCFA causing plaque burden (PB) .70% was identified with intravascular ultrasound evaluation. 4 The aim of the present study was to evaluate the long-term prognostic role of non-obstructive plaque characteristics evaluated with CCTA in a homogenous and selected population of patients with non-obstructive CAD.
Methods Patients selection and characteristics
From a registry of consecutive patients undergoing CCTA from April 2004 to April 2007 for suspected but unknown stable CAD, we retrospectively identified 634 consecutive patients with non-obstructive CAD. Non-obstructive plaques was defined as the presence of coronary artery plaques (stenosis .0 and ,50%). We excluded from the analysis 369 of them because they presented both non-obstructive plaques and obstructive plaques at CCTA evaluation. Therefore, the analytic study population was made up by 265 patients. All patients were evaluated for the presence of traditional cardiovascular risk factors such as diabetes mellitus (glucose level of .7 mmol/L or the need for insulin or oral hypoglycaemic agents), hypercholesterolaemia (total cholesterol level .5 mmol/L or treatment with lipid-lowering drugs), hypertension (blood pressure .140/90 s mmHg or use of anti-hypertensive medications), positive family history of CAD [presence of CAD in first-degree relatives younger than 55 years (male) or 65 years (female)], current smoking. Morise score was calculated for every patients. 5 All patients gave written informed consent and the local ethics committee approved the study.
Scanning protocol and imaging evaluation
A 64-slice scanner (VCT, GE Medical System, Milwaukee WI with 640 × 625 mm collimation and 300-ms gantry rotation time) was used and tube voltage and tube current were tailored to patient body mass index. A bolus of 80 mL of high concentration contrast (Iomeron 400 mg/mL, Bracco Imaging, Milan, Italy) was administered intravenously at 5 mL/s, followed by 50 mL of saline injected at the same infusion rate. The scan was initiated according to the bolustracking technique. All CCTA scans were evaluated for the presence of non-evaluable segments. Coronary arteries were divided into 16 segments according to the American Heart Association classification. 6 Coronary plaques were defined as structures of at least 1 mm 2 area within and/or adjacent to artery lumen, clearly distinguishable from the vessel lumen, and surrounded by pericardial tissue. Arterial remodelling index (RI) assessed using vessel area (RI ¼ lesion plaque area/reference area) and PB [PB ¼ (lesion plaque area 2 lesion lumen area)/lesion plaque area] were evaluated for each coronary plaque detected by CCTA. Plaque attenuation was assessed using Hounsfield Unit (HU). Napkin-ring sign was defined as the presence of a semicircular thin enhancement around the plaque along the outer contour of the vessel, 7 while small spotty calcifications (SCs) were defined as the presence of calcification with a diameter ,2 mm, as previously described 8 ( Figure 1 ). 
Figure 1

Statistical analysis
Statistical analysis was performed using MedCalc (version 11.6.1.0, MedCalc Software; 1993-2011). Statistical significance was defined as a P , 0.05. Continuous variables are presented as mean + SD and categorical variables as absolute numbers and percentages. When not normally distributed, continuous variables are expressed as median (interquartile range). Cox regression analysis was used in order to evaluate the relationship between clinical and CCTA variables and outcomes at univariate analysis. Significant clinical and CCTA variables were evaluated at multivariate analysis. In order to avoid overfitting, plaque characteristics were included in separate models. Events-free survival rates as a function over time were obtained by the Kaplan -Meier method and compared using the log-rank test. Cohen kappa statistics were calculated in 10% of the analysis as measures of inter-observer agreement for plaque characteristics evaluated as dichotomic variables.
Results
Of the 265 patients retrospectively enrolled, 3 were excluded because CCTA images were not evaluable. Of the remaining 262 subjects, a mean follow-up of 98 + 20 months was obtained in 245 (93.5%) patients, while the remaining 17 (6.5%) subjects were lost at follow-up.
A total of 28 events were recorded (2 STEMI, 4 NSTEMI, 6 UA, 2 cardiac deaths, 4 non-cardiac death, and 10 vl-ERs) in 28 different patients. No elective revascularizations before 365 day from baseline CCTA occurred.
Clinical characteristics
The mean population age was 63 + 9 years and among all study subjects we found a male prevalence of 69.8% (171/245). Symptoms at the time of CCTA were typical (5.7%) or atypical chest pain (43.7%) and dyspnoea (10.2%), while 99 patients (40.4%) were asymptomatic; the study population had an intermediate probability of CAD evaluated by the Morise score ( Table 1) .
Among clinical variables b-blockers use was slightly associated with a higher risk of hard cardiac events ( Table 2) , age with an higher risk of both hard and all events, while current smoking was associated with hard events only ( Tables 2 and 3 ).
CCTA characteristics
At least one plaque presenting PRI . 1.1 was found in 196 patients (80%), while PRI . Continuous variables are presented as mean + SD; categorial variables are presented as n (%). CAD, coronary artery disease; ACE-i, angiotensin converting enzyme inhibitors; AT1-blockers, angiotensin 1-blockers; CCTA, coronary computed tomography angiography; PRI, positive remodelling index; LAP, low-atteuation plaque; PB, plaque burden; SC, spotty calcifications; NRS, napkin-ring sign; SIS, segment-involvement score.
PB higher than 0.7 (PB . 0.7), LAP, and napkin-ring sing (NRS) were less prevalent in the population study (respectively, 11 patients, 4.5%; 8 patients, 3.3%; 3 patients, 1.2%) compared with both PRI and SC. Low-to-intermediate values of segment-involvement score were found both in patients with and without events ( Tables 2 and 3 ). An almost perfect inter-observer agreement was found for PRI .
At univariate analysis, the presence of at least one plaque with PB . 0.7 (HR 6.16, 95% CI 1.72-21.9, P ¼ 0.0206), LAP (HR 11.32, 95% CI 3.12-41.02, P ¼ 0.0037), and NRS (HR 7.7, 95% CI 1.01-58.79, P ¼ 0.05) was associated with a statistically higher rate of hard cardiac events at follow-up. Spotty calcification and PRI . 1.1 were not predictive of hard cardiac events. Of note, patients with at least one plaque with PRI . 1.4 result to have higher risk of hard cardiac events (HR 3.40, 95% CI 1.14-10.10, P ¼ 0.0242) ( Table 2) .
Moreover, the presence of at least one plaque with PRI . The Kaplan-Meyer curves showed that cumulative hard cardiac events-free survival was 70% in those patients presenting at least one coronary plaque with two or more high-risk characteristics (PRI . 1.4, PB . 0.7, LAP, or NRS) on the same plaque and 93% in patient with no lesion with more than one high-risk plaque characteristics (log-rank P , 0.0001) (Figure 2) .
Moreover, when all cardiac events, hard events, and all events were used as combined endpoints; a significantly lower events-free survival rates (70, 58.8, and 58.8%, respectively, P , 0.0001 for all combined endpoints) were found in patients with at least one coronary plaque with two or more high-risk characteristics (Figure 2) . Of note, the presence of at least 2 high-risk plaque characteristics on the same plaque was significantly associated to all combined endpoints both at univariate and multivariate analysis (Tables 2 -4).
Discussion
Coronary computed tomography angiography (CCTA) recently emerged as a promising non-invasive tool able not only to identify coronary artery stenoses or to exclude CAD, but also to assess the characteristics of atherosclerotic plaques itself. 12, 16, 17 Some authors suggested that atheromatous plaques presenting positive remodelling and low plaque density at CCTA evaluation may be associated with higher risk of future MACE. 9, 18 However, all these studies were limited by a relatively short follow-up and, even more importantly, by the inclusion of heterogeneous groups of patients.
To the best of our knowledge, this study has the longest followup when compared with previous studies on this topic and its results were obtained in a selected and homogeneous population of nonobstructive CAD patients. This looks like the most appropriate clinical scenario for evaluating the influence of plaque characteristics on future ACS. Moreover, patients with low-to-intermediate prevalence of CAD represent the most suitable population for the assessment of coronary vessel anatomy by CCTA. 19 Among clinical variables, only b-blockers appears to be weakly associated with higher rates of cardiovascular events. This appears to be in accordance with previous reports suggesting that b-blockers use tend to increase the prevalence of body weight and to favour new-onset diabetes 20 ; however, this result is supported by only slightly statistical significance and appears far from conclusive. On the contrary smoke attitude and older age are well-known risk factors.
The main findings of this study are that the morphological characteristics of atherosclerotic plaques (PRI . 1.4, PB . 0.7, LAP, and NRS) obtained with CCTA correlate with long-term cardiovascular prognosis in a population of patients with non-obstructive CAD. Napkin-ring sign was found to be associated to hard-cardiac events, but does not reach statistical significance when combined endpoints including all cause of death and very late coronary revascularizations were considered. This finding could be explained by the lowprevalence of NRS in the study population and is in accordance with by previous findings in which NRS was identified as significant predictor of ACS. 21, 22 We suggest an higher cut-off value (.1.4) for PRI that appeared significantly correlated to hard events when compared with that used in previous studies in this field (PRI . 1.1) that was not associated to hard events in our population of non-obstructive CAD. In our opinion, an higher cut-off for PRI may be biologically rational. Indeed, it is consistent with previous case -control and pathology studies reporting even PRI . 2 to be associated with ACS and vulnerable characteristics of plaque such as TCFA (11-12-22) .
The presence of at least 2 high-risk characteristics among on the same plaque was associated with reduced events-free survival at Kaplan -Meyer curves analysis and was significantly associated with all combined endpoints both at univariate and multivariate Adjusted for age and current smoke.
Non-obstructive coronary plaques evaluated by CCTA analyses; this finding underlines the importance of a comprehensive coronary atherosclerosis evaluation even taking into consideration the low prevalence of some high-risk plaque characteristics. The annualized hard cardiac event rate of patients presenting high-risk non-obstructive CAD in this study (3.7%) was comparable, even if lower than previously reported annual hard cardiac event rate for patients with obstructive CAD (from 1.44 to 9.79%). 23 All together, these findings support recent advances in the knowledge of ACS pathophysiology. 24 
Clinical implications
Before the 'CCTA era', patients with non-obstructive CAD were often overlooked and, in the absence of inducible ischaemia, they were included without any distinction in the same group of those without CAD. On the contrary, among patients with nonobstructive CAD, those with low-risk plaque morphology (Figure 3 ) may be differentiated from those in whom plaque characteristics are associated with an increased risk of future events (Figure 4) , although the presence of high-risk plaques is but one factor in the more complex framework of ACS pathophysiology. 24 It should be noted that this risk may be underestimated if these patients first undergo a provocative test that most of the time turns out negative causing a misjudgement as to what their real cardiovascular prognosis could be. Of interest, 99 subjects (40.4%) had no cardiac symptoms suggesting a possible role of CCTA for cardiovascular risk stratification in asymptomatic high-risk patients (particularly those with diabetes or family history of CAD). However, from our data, it is not possible to infer about the role of CCTA in primary prevention setting and further data are needed to be collected on this topic.
Moreover, the absolute risk of events of our study population is, as expected, quite low and preventive therapies for low-risk patients need to be well-balanced, taking into consideration possible adverse effects and costs that may not be negligible.
Limitations
First, this is a single-centre study evaluating mainly Caucasian patients and its results may not necessarily reflect the patient population of other centres or countries.
Second, we recognize that incomplete follow-up may have resulted in underreporting of cardiac events. However, the Figure 2 Kaplan-Meier analysis. Kaplan-Meier curves for hard cardiac events (A), all cardiac events (B), hard events (C), and all events (D); the 98-months cumulative events-free survival rates were lower among patients with at least 1 plaque with 2 or more high-risk characteristics compared with patients with no lesion with more than one high-risk plaque characteristics on the same plaque (log-rank P , 0.0001 for all four combined endpoints).
percentage of patients with complete follow-up was high (92.4%) and similar to that of previous prognostic studies. 23 Third different scan parameters, accordingly to different BMI values, were used among patients enrolled in the study and this could have an influence on plaque attenuation value, as previously reported in vitro. 25 However, a uniform scan parameters for every patients is not sustainable in clinical practice. Fourth, patients could have modified medication use or lifestyle after CCTA; we were not able to evaluate the influence of this possible bias on our results. However, the probability of significative modifications in medication use or lifestyle after CCTA showing the absence of obstructive CAD is quite low.
Finally, important limitations of our study were the quite low prevalence of high-risk patients and of some plaque characteristics in addition to the relatively small number of events occurring in a middle-sized patient population. Yet, our population was more selected and homogenous when compared with those enrolled in previous studies. 9 Multicentre trials enrolling a larger number of patients will be needed to confirm the potential role of plaque characteristics evaluation with CCTA as a mean to predict future cardiac events in everyday clinical practice.
Conclusions
Despite more data need to be collected, our results suggest that high PRI (cut-off .1.4), LAP (cut-off ,30 HU), PB (cut-off .0.7), and NRS are the most promising plaque characteristics for detecting patients who have a higher risk of hard events at long-term followup among those showing non-obstructive CAD at CCTA evaluation. CCTA could be a first-line test in patients with suspected CAD as it enables identification of a higher-risk group of patients with nonobstructive CAD whose risk could be likely overlooked if functional tests were used as first step. 
